The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.

MLA

Dai, Chia-Yen, et al. “The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.” Biomedicines, vol. 10, no. 7, June 2022. EBSCOhost, https://doi.org/10.3390/biomedicines10071487.

APA

Dai, C.-Y., Fang, T.-J., Hung, W.-W., Tsai, H.-J., & Tsai, Y.-C. (2022). The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Biomedicines, 10(7). https://doi.org/10.3390/biomedicines10071487

Chicago

Dai, Chia-Yen, Tzu-Jung Fang, Wei-Wen Hung, Hui-Ju Tsai, and Yi-Chun Tsai. 2022. “The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.” Biomedicines 10 (7). doi:10.3390/biomedicines10071487.